PortfoliosLab logoPortfoliosLab logo
CYTK vs. VOO
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

CYTK vs. VOO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cytokinetics, Incorporated (CYTK) and Vanguard S&P 500 ETF (VOO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CYTK achieves a 33.57% return, which is significantly higher than VOO's 11.31% return. Over the past 10 years, CYTK has outperformed VOO with an annualized return of 23.96%, while VOO has yielded a comparatively lower 15.29% annualized return.


CYTK

1D
-1.39%
1M
20.98%
6M
35.77%
YTD
33.57%
1Y
129.32%
3Y*
34.18%
5Y*
34.07%
10Y*
23.96%

VOO

1D
0.46%
1M
2.04%
6M
9.36%
YTD
11.31%
1Y
22.48%
3Y*
21.08%
5Y*
13.22%
10Y*
15.29%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CYTK vs. VOO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CYTK
Cytokinetics, Incorporated
33.57%35.08%-43.66%82.21%0.53%119.35%95.85%67.88%-22.45%-32.92%
VOO
Vanguard S&P 500 ETF
11.31%17.82%24.98%26.32%-18.17%28.79%18.32%31.37%-4.50%21.77%

Correlation

The correlation between CYTK and VOO is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.27

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.31

Correlation (10Y)
Calculated over the trailing 10-year period

0.33

Correlation (All Time)
Calculated using the full available price history since Sep 9, 2010

0.32

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CYTK vs. VOO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CYTK
CYTK Risk / Return Rank: 9595
Overall Rank
CYTK Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
CYTK Sortino Ratio Rank: 9595
Sortino Ratio Rank
CYTK Omega Ratio Rank: 9393
Omega Ratio Rank
CYTK Calmar Ratio Rank: 9898
Calmar Ratio Rank
CYTK Martin Ratio Rank: 9797
Martin Ratio Rank

VOO
VOO Risk / Return Rank: 6868
Overall Rank
VOO Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
VOO Sortino Ratio Rank: 6666
Sortino Ratio Rank
VOO Omega Ratio Rank: 6868
Omega Ratio Rank
VOO Calmar Ratio Rank: 6262
Calmar Ratio Rank
VOO Martin Ratio Rank: 7474
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CYTK vs. VOO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cytokinetics, Incorporated (CYTK) and Vanguard S&P 500 ETF (VOO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CYTKVOODifference
Sharpe ratioReturn per unit of total volatility

+0.41

Sortino ratioReturn per unit of downside risk

+1.16

Omega ratioGain probability vs. loss probability

1.42

1.32

+0.10

Calmar ratioReturn relative to maximum drawdown

8.84

2.49

+6.36

Martin ratioReturn relative to average drawdown

19.45

10.85

+8.60

CYTK vs. VOO - Sharpe Ratio Comparison

The current CYTK Sharpe Ratio is 2.19, which is comparable to the VOO Sharpe Ratio of 1.77. The chart below compares the historical Sharpe Ratios of CYTK and VOO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CYTK vs. VOO - Drawdown Comparison

The maximum CYTK drawdown since its inception was -97.09%, which is greater than VOO's maximum drawdown of -33.99%. Use the drawdown chart below to compare losses from any high point for CYTK and VOO.


Loading charts...

Drawdown Indicators


CYTKVOODifference

Max Drawdown

Largest peak-to-trough decline

-97.09%

-33.99%

-63.10%

Max Drawdown (1Y)

Largest decline over 1 year

-15.01%

-8.90%

-6.11%

Max Drawdown (3Y)

Largest decline over 3 years

-72.39%

-18.69%

-53.70%

Max Drawdown (5Y)

Largest decline over 5 years

-72.39%

-24.52%

-47.87%

Max Drawdown (10Y)

Largest decline over 10 years

-72.39%

-33.99%

-38.40%

Current Drawdown

Current decline from peak

-21.46%

-0.34%

-21.12%

Average Drawdown

Average peak-to-trough decline

-75.82%

-3.68%

-72.14%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.81%

2.04%

+4.77%

Volatility

CYTK vs. VOO - Volatility Comparison

Cytokinetics, Incorporated (CYTK) has a higher volatility of 10.02% compared to Vanguard S&P 500 ETF (VOO) at 4.42%. This indicates that CYTK's price experiences larger fluctuations and is considered to be riskier than VOO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CYTKVOODifference

Volatility (1M)

Calculated over the trailing 1-month period

10.02%

4.42%

+5.60%

Volatility (6M)

Calculated over the trailing 6-month period

32.41%

9.94%

+22.47%

Volatility (1Y)

Calculated over the trailing 1-year period

60.74%

12.48%

+48.26%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

70.03%

16.92%

+53.11%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

68.02%

17.99%

+50.03%

Dividends

CYTK vs. VOO - Dividend Comparison

CYTK has not paid dividends to shareholders, while VOO's dividend yield for the trailing twelve months is around 1.06%.


PositionTTM20252024202320222021202020192018201720162015
CYTK
Cytokinetics, Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VOO
Vanguard S&P 500 ETF
1.06%1.13%1.24%1.46%1.69%1.25%1.54%1.88%2.06%1.78%2.02%2.10%

Frequently Asked Questions


CYTK and VOO have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CYTK has higher volatility (10.02%) compared to VOO (4.42%). In terms of maximum drawdown, CYTK dropped -97.09% vs VOO's -33.99%.

CYTK currently has the higher Sharpe Ratio (2.19 vs 1.77), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CYTK and VOO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer